找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202

[復(fù)制鏈接]
樓主: Clinton
41#
發(fā)表于 2025-3-28 16:49:03 | 只看該作者
42#
發(fā)表于 2025-3-28 19:36:14 | 只看該作者
https://doi.org/10.37307/b.978-3-503-20630-8. Sometimes pragmatic choices need to be made between candidate diagnostic frameworks. Various kinds of diagnostic difficulty are explored, including differences between research and clinical diagnostic categories, “not otherwise specified” categories, and stigmatized diagnoses.
43#
發(fā)表于 2025-3-29 02:47:03 | 只看該作者
44#
發(fā)表于 2025-3-29 06:29:20 | 只看該作者
45#
發(fā)表于 2025-3-29 08:39:16 | 只看該作者
Friedrich Rüffler,Robert A. Steinwenderationally agreed-upon classification system of disease (ICD). It is a complex process in which over 50 factors are known to exert an influence. They include individual characteristics of the clinician and their cognitive styles, ambient conditions, ergonomic features of the workplace, the patient an
46#
發(fā)表于 2025-3-29 13:11:05 | 只看該作者
47#
發(fā)表于 2025-3-29 19:20:51 | 只看該作者
Erkrankungen von Leber und Gallenwegen,universe of patients that could benefit from a novel therapy but the majority of patients with shared features of a disease. This framework fits the current model of clinical development and regulatory approval, but it must evolve when studying complex diseases which have multifactorial etiology and
48#
發(fā)表于 2025-3-29 22:09:38 | 只看該作者
49#
發(fā)表于 2025-3-30 02:49:54 | 只看該作者
https://doi.org/10.1007/978-3-531-90010-0 The Agency has a series of well-publicized review processes, thus ensuring that appropriate standards of safety and efficacy are met. The FDA also has emergency procedures available to expedite approval in special circumstances, such as a completely new treatment or a national emergency. The FDA do
50#
發(fā)表于 2025-3-30 07:30:04 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 03:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
陕西省| 邵阳市| 上虞市| 霍州市| 南康市| 湟中县| 浪卡子县| 海城市| 金门县| 佳木斯市| 平南县| 岳阳市| 海阳市| 广州市| 如东县| 盐池县| 息烽县| 绥芬河市| 平安县| 梅州市| 徐汇区| 外汇| 吴旗县| 额尔古纳市| 广平县| 潼关县| 额济纳旗| 思南县| 崇礼县| 茂名市| 鄯善县| 治县。| 洛隆县| 涿州市| 班戈县| 海晏县| 昌宁县| 阿拉善左旗| 固阳县| 柳江县| 红河县|